Raptiva is once-a-week injection for treatment of psoriasis. It was pulled from the U.S. market on April 8, 2009. It was withdrawn because Raptiva suppresses the immune system, which increases the risk of serious infections, including a rare viral brain infection known as progressive multifocal leukoencephalopathy (PML).

We are investigating cases of PML and other serious infections acquired by people when being treated with Raptiva.

If you feel you have suffered as a result of Raptiva please reivew and fill out the below questionnaire. You may also call Maguire & Schneider to discuss your legal rights.

http://www.ms-lawfirm.com/news/2009/04/raptiva_questionnaire.shtml

If you are currently a member of Pre-Paid Legal, contact us at 1-800-464-2266.

If you are not currently a member, contact us at 1-800-600-1222.